|Day Low/High||1.83 / 1.89|
|52 Wk Low/High||0.15 / 1.40|
Proceeds to support corporate growth strategy
Financial executive with extensive public-company experience to help strengthen the Company's foundation and position for growth
Arsenal™ AIS System Used to Successfully Treat First Adolescent Patients
Brings over 28 years of orthopedic and medical device experience to Alphatec
Substantially reduced debt and improved balance sheet strengthens Alphatec's financial position and enables future growth strategies
Shares of Common Stock Will Begin Trading on a Split-Adjusted Basis on August 25, 2016
Cash proceeds of $80 million to substantially reduce Company's outstanding debt, allow for continued investment in commercialization and expansion of U.S. business
The $1 billion transaction could inspire other medical device companies and private equity firms to bend over backwards for spinal device assets.
Company Announces Extension of Credit Agreement Maturity
These five stocks look ready to trigger big breakout trades.